Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

328 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Variants in interferon-alpha pathway genes and response to pegylated interferon-Alpha2a plus ribavirin for treatment of chronic hepatitis C virus infection in the hepatitis C antiviral long-term treatment against cirrhosis trial.
Welzel TM, Morgan TR, Bonkovsky HL, Naishadham D, Pfeiffer RM, Wright EC, Hutchinson AA, Crenshaw AT, Bashirova A, Carrington M, Dotrang M, Sterling RK, Lindsay KL, Fontana RJ, Lee WM, Di Bisceglie AM, Ghany MG, Gretch DR, Chanock SJ, Chung RT, O'Brien TR; HALT-C Trial Group. Welzel TM, et al. Among authors: sterling rk. Hepatology. 2009 Jun;49(6):1847-58. doi: 10.1002/hep.22877. Hepatology. 2009. PMID: 19434718 Free PMC article.
Flumazenil for hepatic coma: the elusive wake-up call?
Sterling RK, Shiffman ML, Schubert ML. Sterling RK, et al. Gastroenterology. 1994 Oct;107(4):1204-5. doi: 10.1016/0016-5085(94)90252-6. Gastroenterology. 1994. PMID: 7926473 No abstract available.
Treatment of chronic hepatitis C in patients who failed interferon monotherapy: effects of higher doses of interferon and ribavirin combination therapy. The Virginia Cooperative Hepatitis Treatment Group.
Shiffman ML, Hofmann CM, Gabbay J, Luketic VA, Sterling RK, Sanyal AJ, Contos MJ, Ryan MJ, Yoshida C, Rustgi V. Shiffman ML, et al. Among authors: sterling rk. Am J Gastroenterol. 2000 Oct;95(10):2928-35. doi: 10.1111/j.1572-0241.2000.02321.x. Am J Gastroenterol. 2000. PMID: 11051370 Clinical Trial.
Chronic infection with hepatitis C virus in patients with elevated or persistently normal serum alanine aminotransferase levels: comparison of hepatic histology and response to interferon therapy.
Shiffman ML, Stewart CA, Hofmann CM, Contos MJ, Luketic VA, Sterling RK, Sanyal AJ. Shiffman ML, et al. Among authors: sterling rk. J Infect Dis. 2000 Dec;182(6):1595-601. doi: 10.1086/317612. Epub 2000 Oct 23. J Infect Dis. 2000. PMID: 11069229 Clinical Trial.
A multicenter, randomized trial of daily high-dose interferon-alfa 2b for the treatment of chronic hepatitis c: pretreatment stratification by viral burden and genotype.
Fried MW, Shiffman M, Sterling RK, Weinstein J, Crippin J, Garcia G, Wright TL, Conjeevaram H, Reddy KR, Peter J, Cotsonis GA, Nolte FS. Fried MW, et al. Among authors: sterling rk. Am J Gastroenterol. 2000 Nov;95(11):3225-9. doi: 10.1111/j.1572-0241.2000.03433.x. Am J Gastroenterol. 2000. PMID: 11095346 Clinical Trial.
A randomized, controlled trial to determine whether continued ribavirin monotherapy in hepatitis C virus-infected patients who responded to interferon-ribavirin combination therapy will enhance sustained virologic response.
Shiffman ML, Hofmann CM, Sterling RK, Luketic VA, Contos MJ, Sanyal AJ. Shiffman ML, et al. Among authors: sterling rk. J Infect Dis. 2001 Aug 15;184(4):405-9. doi: 10.1086/322778. Epub 2001 Jul 16. J Infect Dis. 2001. PMID: 11471097 Clinical Trial.
The clinical spectrum of hepatitis C virus in HIV coinfection.
Sterling RK, Contos MJ, Sanyal AJ, Luketic VA, Stravitz RT, Wilson MS, Mills AS, Shiffman ML. Sterling RK, et al. J Acquir Immune Defic Syndr. 2003 Jan 1;32(1):30-7. doi: 10.1097/00126334-200301010-00005. J Acquir Immune Defic Syndr. 2003. PMID: 12514411
328 results